Screener
BioCryst Pharmaceuticals BCRX Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's operating lease liability payments due?
- BioCryst Pharmaceuticals (BCRX) reported operating lease liability payments due of $18.18M in Q2 2026.
- How has BioCryst Pharmaceuticals's operating lease liability payments due changed year-over-year?
- BioCryst Pharmaceuticals's operating lease liability payments due increased by 20.1% year-over-year, from $15.15M to $18.18M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.
Ask your AI about BioCryst Pharmaceuticals's operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude